Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

J. Bjorkander; J. Nikoskelainen; H. Leibl; P. Lanbeck; J. Wallvik; J. T. Lumio; J. H. Braconier; B. G. Pavlova; K. Birthistle; W. Engl; S. Walter; H. J. Ehrlich

doi:10.1111/j.1423-0410.2006.00764.x

Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

Vox Sanguinis ◽

10.1111/j.1423-0410.2006.00764.x ◽

2006 ◽

Vol 90 (4) ◽

pp. 286-293 ◽

Cited By ~ 41

Author(s):

J. Bjorkander ◽

J. Nikoskelainen ◽

H. Leibl ◽

P. Lanbeck ◽

J. Wallvik ◽

...

Keyword(s):

Intravenous Immunoglobulin ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

Journal of Clinical Immunology ◽

10.1007/s10875-017-0424-4 ◽

2017 ◽

Vol 37 (6) ◽

pp. 603-612 ◽

Cited By ~ 3

Author(s):

Michael Borte ◽

Isaac R. Melamed ◽

Grazyna Pulka ◽

Barbara Pyringer ◽

Alan P. Knutsen ◽

...

Keyword(s):

Intravenous Immunoglobulin ◽

Primary Immunodeficiency ◽

Efficacy And Safety ◽

Primary Immunodeficiency Diseases ◽

Open Label ◽

Two Stage ◽

Open Label Study ◽

Label Study ◽

Immunodeficiency Diseases ◽

Human Intravenous Immunoglobulin

Download Full-text

THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01800-3 ◽

2021 ◽

Vol 77 (18) ◽

pp. 441

Author(s):

Eric Bruckert ◽

Sonia Caprio ◽

Albert Wiegman ◽

Min-Ji Charng ◽

Cézar A. Zárate-Morales ◽

...

Keyword(s):

Children And Adolescents ◽

Familial Hypercholesterolemia ◽

Efficacy And Safety ◽

Homozygous Familial Hypercholesterolemia ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study

Download Full-text

Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study

Annals of Dermatology ◽

10.5021/ad.2015.27.4.371 ◽

2015 ◽

Vol 27 (4) ◽

pp. 371 ◽

Cited By ~ 9

Author(s):

Jung-Min Park ◽

Hyun-Ho Cho ◽

Won-Jeong Kim ◽

Je-Ho Mun ◽

Margaret Song ◽

...

Keyword(s):

Betamethasone Dipropionate ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Calcipotriol Betamethasone

Download Full-text

Efficacy and Safety of Thirst-Quenching Lozenges for Xerostomia in Patients Undergoing Hemodialysis: A Prospective, Single-Arm, Open-Label Study

Journal of Clinical Nephrology and Renal Care ◽

10.23937/2572-3286.1510056 ◽

2020 ◽

Vol 6 (2) ◽

Author(s):

Sahay Manisha ◽

Almeida Alan ◽

Naqvi Syed Mujtaba Hussain ◽

Venugopal Hariharan ◽

Kale Ravindra Machhindra ◽

...

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Gastroenterology ◽

10.1053/j.gastro.2015.07.001 ◽

2015 ◽

Vol 149 (4) ◽

pp. 971-980.e1 ◽

Cited By ~ 59

Author(s):

Eric Lawitz ◽

Mihály Makara ◽

Ulus Salih Akarca ◽

Paul J. Thuluvath ◽

Liliana Lucia Preotescu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Efficacy And Safety ◽

Hepatitis C Virus Infection ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Chronic Hepatitis C Virus

Download Full-text

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s79347 ◽

2015 ◽

pp. 1349 ◽

Cited By ~ 3

Author(s):

Ernie Anand ◽

Lovisa Berggren ◽

Claudia Deix ◽

Ágoston Tóth ◽

David McDonnell

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Post Hoc Analysis ◽

Long Acting ◽

Post Hoc

Download Full-text

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.14294 ◽

2018 ◽

Vol 45 (5) ◽

pp. 529-539 ◽

Cited By ~ 26

Author(s):

Shigetoshi Sano ◽

Hiroshi Kubo ◽

Hitomi Morishima ◽

Ryosuke Goto ◽

Richuan Zheng ◽

...

Keyword(s):

Monoclonal Antibody ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Generalized Pustular Psoriasis ◽

Erythrodermic Psoriasis ◽

Interleukin 23

Download Full-text

Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study

European Urology ◽

10.1159/000020056 ◽

1999 ◽

Vol 36 (6) ◽

pp. 609-620 ◽

Cited By ~ 52

Author(s):

C.C. Schulman ◽

J. Cortvriend ◽

U. Jonas ◽

T.M.T.W. Lock ◽

S. Vaage ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Efficacy And Safety ◽

Benign Prostatic Obstruction ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)

BMC Endocrine Disorders ◽

10.1186/s12902-020-0524-7 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Zhenmei An ◽

◽

Ting Lei ◽

Lian Duan ◽

Pei Hu ◽

...

Keyword(s):

Chinese Patients ◽

Prolonged Release ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Active Acromegaly ◽

Lanreotide Autogel

Download Full-text

1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel cell carcinoma progressing on anti-PD-(L)1 antibody therapy: The MERKLIN 2 study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1276 ◽

2020 ◽

Vol 31 ◽

pp. S767-S768

Author(s):

A.C.J. van Akkooi ◽

P.A. Ascierto ◽

J.C. Becker ◽

P. Nathan ◽

P. Nghiem ◽

...

Keyword(s):

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Phase Ii ◽

Antibody Therapy ◽

Merkel Cell ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text